Skip to content

Clinical trials

Immune System Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Country / region: United Kingdom Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20122
20142
20152
20164
20173
20184
20194
20204
20213
20225
20234
20241
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting9
Terminated7
Active, not recruiting7
Unknown status4
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Novartis Pharmaceuticals3
Cogent Biosciences, Inc.2
Takeda2
Acerta Pharma BV1
Adienne SA1
Alumis Inc1
Ariad Pharmaceuticals1
Asger Sverrild1
Barts & The London NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases48
Autoimmune Diseases21
Connective Tissue Diseases8
Immunoproliferative Disorders8
Hematologic Diseases7
Lupus Erythematosus, Systemic7
Hypersensitivity6
Neoplasms6
Lymphatic Diseases5
Lymphoma5

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.